Meloxicam-associated anaphylactic reaction.

Area of Science:

• Pharmacology
• Immunology
• Clinical Medicine

Background:

• Meloxicam is a widely used nonsteroidal anti-inflammatory drug (NSAID) belonging to the selective cyclooxygenase 2 (COX-2) inhibitor class.
• Anaphylaxis is a severe, potentially life-threatening allergic reaction.
• Previous literature has not documented cases of anaphylaxis specifically linked to meloxicam.

Observation:

• This report details two distinct cases of patients experiencing anaphylactic reactions.
• These reactions occurred shortly after the administration of meloxicam.
• Crucially, both patients demonstrated no signs of hypersensitivity when challenged with a different selective COX-2 inhibitor.

Findings:

• The findings indicate that meloxicam can indeed trigger anaphylactic reactions, a phenomenon previously unreported.
• Importantly, cross-reactivity to other selective COX-2 inhibitors was not observed in these cases.
• This suggests a specific hypersensitivity to meloxicam itself.

Implications:

• Healthcare providers should consider meloxicam as a potential cause of anaphylaxis in patients presenting with allergic symptoms after NSAID use.
• A comprehensive drug allergy evaluation is recommended before prescribing alternative COX-2 inhibitors to patients with a history of suspected meloxicam-induced anaphylaxis.
• These findings highlight the importance of detailed patient history and allergy testing in NSAID prescribing practices.